16034-49-4

Usage

Uses

Used in Organic Synthesis:
(3,5-DIMETHYL-PYRAZOL-1-YL)-ACETIC ACID is used as a building block in organic synthesis for the creation of various functionalized pyrazole derivatives. Its structural features allow for the development of compounds with potential applications in different fields.
Used in Pharmaceutical Research:
In pharmaceutical research, (3,5-DIMETHYL-PYRAZOL-1-YL)-ACETIC ACID is utilized as an intermediate for the synthesis of pyrazole-based drugs. Its unique properties make it a valuable component in the design and development of new pharmaceutical agents.
Used in Drug Discovery and Development:
(3,5-DIMETHYL-PYRAZOL-1-YL)-ACETIC ACID is considered in drug discovery and development due to its potential biological activity. Its structural properties may contribute to the creation of novel therapeutic agents.
Used in Laboratory Settings:
(3,5-DIMETHYL-PYRAZOL-1-YL)-ACETIC ACID is used as a reagent or catalyst in laboratory settings to facilitate various chemical reactions. Its presence can enhance the efficiency and selectivity of these processes.
Used in Chemical Reactions:
In the context of chemical reactions, (3,5-DIMETHYL-PYRAZOL-1-YL)-ACETIC ACID is employed to catalyze or act as a reagent, contributing to the advancement of chemical processes and the synthesis of new compounds.

InChI:InChI=1/C7H10N2O2/c1-5-3-6(2)9(8-5)4-7(10)11/h3H,4H2,1-2H3,(H,10,11)/p-1

Upstream product

• 79559-08-3 methyl 2-(3,5-dimethyl-1H-pyrazol-1-yl)acetate 
• 1449369-11-2 benzyl 2-(3,5-dimethyl-1H-pyrazol-1-yl)acetate 
• 67-51-6 3,5-dimethyl-1H-pyrazole 
• 10199-60-7 ethyl 2-(3,5-dimethyl-1H-pyrazol-1-yl)acetate 
• 79-11-8 chloroacetic acid 

Downstream Products

• 1253383-30-0 2-(3,5-dimethyl-pyrazol-1-yl)-1-[4-(2-nitro-phenyl)-piperazin-1-yl]-ethanone 
• 1253381-44-0 2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-N-phenyl-benzamide 
• 1253383-65-1 1-[4-(5-chloro-3-nitro-pyridin-2-yl)-piperazin-1-yl]-2-(3,5-dimethyl-pyrazol-1-yl)-ethanone 
• 1253383-75-3 3-chloro-N-(5-chloro-2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-[1,4]diazepan-1-yl}-pyridin-3-yl)-benzamide 
• 1253382-57-8 2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-benzoic acid 
• 1253383-31-1 1-[4-(2-amino-phenyl)-piperazin-1-yl]-2-(3,5-dimethyl-pyrazol-1-yl)-ethanone 
• 1253383-29-7 N-(2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-phenyl)-benzamide 
• 1253382-55-6 2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-N-pyridin-4-yl-benzamide 
• 1253383-61-7 3-chloro-N-(5-chloro-2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-pyridin-3-yl)-benzamide 
• 1253383-72-0 N-(5-chloro-2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-pyridin-3-yl)-4-methanesulfonyl-benzamide 
• 1253382-59-0 N-(2-amino-phenyl)-2-{4-[2-(3,5-dimethyl-pyrazol-1-yl)-acetyl]-piperazin-1-yl}-benzamide 
• 1253936-85-4 1-{4-[2-(1H-benzoimidazol-2-yl)phenyl]piperazin-1-yl}-2-(3,5-dimethyl-pyrazol-1-yl)ethanone 
• 1253936-87-6 2-(3,5-dimethyl-pyrazol-1-yl)-1-{4-[2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)phenyl]piperazin-1-yl}ethanone 
• 1449369-11-2 benzyl 2-(3,5-dimethyl-1H-pyrazol-1-yl)acetate 

Relevant academic research and scientific papers

CHEMICAL SUBSTANCES WHICH INHIBIT THE ENZYMATIC ACTIVITY OF HUMAN KALLIKREIN-RELATED PEPTIDASE 6 (KLK6)

The invention relates to compounds which are suitable for the treatment of a disease associated with kallikrein-like peptidase 6 overexpression and to pharmaceutical compositions containing such compounds. The invention further relates to a kit of parts comprising such compounds or pharmaceutical compositions.

COMPOUNDS USEFUL AS CSF1 MODULATORS

This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.